TARRYTOWN, N.Y.--(BUSINESS WIRE)--Feb. 6, 2006--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 8, 2006.
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Feb. 6, 2006--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 8, 2006.
